Skip to content

Multi-center Prospective Observational Cohort Study of Symptomatic Atherosclerotic Non-Acute Internal Carotid Artery Occlusion

Multi-center Prospective Observational Cohort Study of Symptomatic Atherosclerotic Non-Acute Internal Carotid Artery Occlusion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112753
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Atherosclerotic Non-Acute Internal Carotid Artery Occlusion

Interventions

SANICAO Patient Group:none

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age > 18 years; 2.Unilateral internal carotid artery occlusion detected by MRA/CTA/DSA; 3.Time from vascular occlusion to treatment is more than 24 hours (confirmed by imaging or inferred from the responsible event); 4.A responsible event related to the ipsilateral internal carotid artery occlusion occurred within the past 12 months, including one or more of the following: ischemic stroke, TIA (transient ischemic attack), or transient monocular vision loss (patients with only dizziness or headache are considered asymptomatic); 5. mRS <= 3; 6.The patient and their family members are willing to participate in this trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Occlusion caused by the following non-atherosclerotic diseases: such as arterial dissection, large vessel vasculitis, moyamoya disease; vasculitis caused by herpes simplex virus, varicella-zoster virus, or other viruses; neurosyphilis; leptospiral vasculitis; any type of intracranial infection; radiation-induced vascular occlusion; fibromuscular dysplasia; sickle cell anemia, etc.; 2.History of primary intracranial or ventricular hemorrhage; 3;Active bleeding within the past 30 days or known bleeding tendency; 4.History of extracranial-intracranial bypass surgery and/or recanalization treatment for occluded vessels; 5.Coexisting severe diseases or organ failure of important organs such as the heart, liver, kidneys, or lungs; presence of tumors. 6.Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale;National Institutes of Health Stroke Scale;Simple Mental State Screening Scale;Montreal Cognitive Assessment;Stroke Recurrence;Mortality;

Secondary

MeasureTime frame
Quality of Life Score,EQ-5D;Imaging Improvement;Utilization of Medical Resources;

Countries

China

Contacts

Public ContactZhao Xingqi

Shenzhen Second People's Hospital

zwxeqn2117701@163.com+86 191 5408 3523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026